• FirefoxUpgrade to the new Firefox »
  •  Dow Up2.43% Nasdaq Up2.24%

    NovaBay Pharmaceuticals, Inc. (NBY)

    -NYSE MKT
    0.63 0.02(3.08%) Dec 18, 4:02PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 3,477   6,947   11,019  
    Cost of Revenue162  8   -  
    Gross Profit 3,315   6,939   11,019  
    Operating Expenses
    Research Development12,461  9,275  9,911  
    Selling General and Administrative6,340  5,973  5,429  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (15,486) (8,309) (4,321)
    Income from Continuing Operations
    Total Other Income/Expenses Net(554)1,284  (762)
    Earnings Before Interest And Taxes(16,040)(7,025)(5,083)
    Interest Expense -   -   -  
    Income Before Tax(16,040)(7,025)(5,083)
    Income Tax Expense2  2  2  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(16,042)(7,027)(5,085)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (16,042) (7,027) (5,085)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (16,042) (7,027) (5,085)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.